Zymeworks inc.

Major-Pharmaceuticals

ZYME


1385 West 8th Avenue
Vancouver , BC V6H 3V9

Executive/
Director

Price

  • Last Close
  • $ 11.71
    $ +0.33 2.9 %
    Aug 29, 2024
  • 52-Week High/Low
  • $12.9 - $6.18
  • YTD
  • 12.7%

  • Trading Volume
  • 22,644
  • Market Cap Full
  • $ 819.7M
  • Shares Outstanding
  • 70M
    Nov 6, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - 58.4% 10.2% -5% -33.8% -60% 15% 1.3%
Q2 - - -35.8% 22.5% 35.2% 4% 9.9% -19.1% -4.4% -6.6%
Q3 - - -4.4% 4.4% 7% 8% -16.3% 16% -26.6% -
Q4 - - -8% -4.9% 86.8% 3.9% -43.6% 27.8% 67.9% -
J F M A M J J A S O N D
2024 4.3% 10.8% -12.4% -12.3% - - - - - - - -
2023 20.2% -13% 10% -7.1% -2% 5% -13.7% -3% -12.4% 10.7% 26.4% 17.1%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%93%206%6%-66%-52%32%13%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - 1.13 -0.83 -0.43 -0.64 -0.87 -1.19 -0.37
Q2 - - 0.63 -0.22 -0.89 -0.77 -1.31 -0.97 -0.76
Q3 - - 0.65 -0.59 -0.7 -1.43 -1.25 - -0.41
Q4 - - 1.28 0.38 -1.81 -0.74 -1.18 4.78 -
A 0 0 3.7 -1.3 -3.8 -3.6 -4.6 1.9 -1.54

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2022 2023
Mar - 64
Jun - 64.2
Sep - 67.8
Dec 63 70

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 7 0.5 0.7 1 2
Total Asset Turnover 0.6 0.1 0.1 0.1 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 18.7 1 31.2 25.2 -8.3
Equity multiplier 0.1 0.2 0.1 0.1 0.1